Olga Torres of Torres Trade Law told an audience of compliance professionals that a lot of contracts couldn't be fulfilled either because the company couldn't get an export license from the Bureau of ...
Expanded collaboration continues to leverage Congruence's proprietary computational drug discovery engine, Revenir™ to deliver Development Candidates in Neurology and Immunology Congruence to receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results